T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.18% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 14.24% |
| 4 | Technology | 12.89% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
International Bancshares
IBOC
$4.52B
| $573K | ﹤0.01% |
21,954
| – | – |
|
|
WIRE
1902
DELISTED
Encore Wire Corp
WIRE
| $572K | ﹤0.01% |
15,350
| – | – |
|
|
SGMO
1903
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $570K | ﹤0.01% |
98,500
+17,900
| +22% | +$114K |
|
|
MGLN
1904
DELISTED
Magellan Health Services, Inc.
MGLN
| $570K | ﹤0.01% |
8,670
| – | – |
|
|
ALX
1905
Alexander's
ALX
$1.39B
| $567K | ﹤0.01% |
1,386
+1
| +0.1% | +$378 |
|
|
IMPV
1906
DELISTED
Imperva, Inc.
IMPV
| $566K | ﹤0.01% |
13,170
-1,157,645
| -99% | -$48.6M |
|
1907
National Grid
NGG
$81.6B
| $565K | ﹤0.01% |
7,878
| – | – |
|
|
LORL
1908
DELISTED
Loral Space and Communications, Inc.
LORL
| $565K | ﹤0.01% |
+16,030
| New | +$583K |
|
1909
Myriad Genetics
MYGN
$309M
| $562K | ﹤0.01% |
18,380
-3,200
| -15% | -$111K |
|
1910
Trex
TREX
$5.1B
| $556K | ﹤0.01% |
49,520
-10,400
| -17% | -$117K |
|
|
RTEC
1911
DELISTED
Rudolph Technologies Inc
RTEC
| $556K | ﹤0.01% |
35,800
+9,100
| +34% | +$129K |
|
1912
Community Health Systems
CYH
$410M
| $555K | ﹤0.01% |
46,054
-3,875
| -8% | -$56.8K |
|
1913
OFG Bancorp
OFG
$2.26B
| $554K | ﹤0.01% |
66,695
+8,100
| +14% | +$66.1K |
|
1914
VEON
VEON
$3.92B
| $554K | ﹤0.01% |
5,715
+503
| +10% | +$47.2K |
|
1915
Archrock
AROC
$5.84B
| $551K | ﹤0.01% |
58,499
+19,100
| +48% | +$151K |
|
|
ARIA
1916
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $549K | ﹤0.01% |
74,300
| – | – |
|
1917
ABM Industries
ABM
$2.84B
| $548K | ﹤0.01% |
15,024
+34
| +0.2% | +$1.15K |
|
1918
BJ's Restaurants
BJRI
$1.48B
| $548K | ﹤0.01% |
12,493
-3,300
| -21% | -$146K |
|
1919
World Acceptance Corp
WRLD
$875M
| $548K | ﹤0.01% |
12,020
-3,300
| -22% | -$134K |
|
|
SNR
1920
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $548K | ﹤0.01% |
51,350
-8,600
| -14% | -$91.6K |
|
|
FTD
1921
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $548K | ﹤0.01% |
21,975
-700
| -3% | -$18.5K |
|
1922
NatWest
NWG
$76.9B
| $547K | ﹤0.01% |
108,086
+5,572
| +5% | +$39.1K |
|
|
ELNK
1923
DELISTED
EarthLink Holdings Corp.
ELNK
| $546K | ﹤0.01% |
85,370
| – | – |
|
1924
NetEase
NTES
$78.5B
| $545K | ﹤0.01% |
14,100
+4,100
| +41% | +$128K |
|
|
LQ
1925
DELISTED
La Quinta Holdings Inc.
LQ
| $545K | ﹤0.01% |
47,840
+5,600
| +13% | +$66.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.